Received Sep 3, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | N/A | 58160-842-43 | IM / LA |
patient received Tdap on 8/29/25 and developed nausea, diarrhea, headache and upper extremity redness and swelling the following day. symptoms have persisted
none
hypertension
losartan 100mg
lisinopril